Test |!Bank |!- |!Pharmacology: |!A |!Patient-Centered |!Nursing |!Process |!Approach |!(9th |!Edition)
PHARMACOLOGY |!9TH |!EDITION |!MCCUISTION |!TEST |!BANK
This |!is |!a |!set |!of |!questions |!to |!ANSwer |!the |!questions |!of |!the |!textbook |!"Pharmacology: |!A |!Patient-
Centered |!Nursing |!Process |!Approach |!9th |!Edition" |!it |!helps |!you |!to |!better |!understand |!the |!book
|!correctly.
Get |!the |!right |!dosage |!of |!pharmacology |!content |!to |!succeed |!on |!the |!NCLEX |!and |!as |!a |!professional
|!nurse |!with |!"Pharmacology: |!A |!Patient-Centered |!Nursing |!Process |!Approach, |!9th |!Edition". |!Using |!a
|!streamlined |!prototype |!approach |!and |!an |!emphasis |!on |!nursing |!care, |!this |!text |!makes |!it |!easy |!for
|!today’s |!nursing |!students |!to |!better |!understand |!the |!complicated |!subject |!of |!pharmacology. |!The
|!book’s |!detailed |!chapter |!on |!dosage |!calculation, |!the |!nursing |!process |!framework |!for |!drug |!therapy,
|!strong |!QSEN |!focus, |!and |!summaries |!of |!prototype |!drugs |!help |!deliver |!the |!perfect.
,Test |!Bank |!- |!Pharmacology: |!A |!Patient-Centered |!Nursing |!Process |!Approach |!(9th |!Edition)
PHARMACOLOGY |!9TH |!EDITION |!MCCUISTION |!TEST |!BANK
Table of Contents
|! |!
Table |!of |!Contents Chapter |!28: |!Peptides, |!Antimalarial, |!and
Chapter |!01: |!Drug |!Development |!and Anthelmintic
|!Ethical |!Considerations Chapter |!29: |!HIV- |!and |!AIDS-Related
Chapter |!02: |!Pharmacokinetics, |!Drugs
|!Pharmacodynamics, |!and Chapter |!30: |!TrANSplant
|!Pharmacogenetics |!Drugs |!Chapter |!31: |!Vaccines
Chapter |!03: |!Cultural |!Considerations |!Chapter |!32: |!Anticancer |!Drugs
|!Chapter |!04: |!Complementary |!and Chapter |!33: |!Targeted |!Therapies |!to |!Treat
|!Alternative |!Therapies |!Cancer
Chapter |!05: |!Pediatric |!Considerations Chapter |!34: |!Biologic |!Response
|!Chapter |!06: |!Geriatric |!Modifiers
|!Considerations |!Chapter |!07: |!Drugs |!in Chapter |!35: |!Upper |!Respiratory
|!Substance |!Use |!Disorder |!Disorders
Chapter |!08: |!The |!Nursing |!Process |!and Chapter |!36: |!Lower |!Respiratory
|!Patient-Centered |!Care |!Disorders
Chapter |!09: |!Safety |!and |!Quality Chapter |!37: |!Cardiac |!Glycosides,
|!Chapter |!10: |!Drug |!Administration |!Antianginals, |!and |!Antidysrhythmics
|!Chapter |!11: |!Drug |!Calculations |!Chapter |!38: |!Diuretics
|!Chapter |!12: |!Fluid |!Volume |!and Chapter |!39: |!Antihypertensive
|!Electrolytes Chapter |!40: |!Anticoagulants,
Chapter |!13: |!Vitamin |!and |!Mineral |!Antiplatelets, |!and |!Thrombolytics
|!Replacement |!Chapter |!41: |!Antihyperlipidemics |!and
Chapter |!14: |!Nutritional |!Support |!Peripheral |!Vasodilators
|!Chapter |!15: |!Adrenergic |!Agonists |!and Chapter |!42: |!Gastrointestinal |!Tract
|!Antagonists |!Disorders
Chapter |!16: |!Cholinergic |!Agonists |!and Chapter |!43: |!Antiulcer |!Drugs
|!Antagonists |!Chapter |!44: |!Eye |!and |!Ear
Chapter |!17: |!Stimulants |!Disorders |!Chapter |!45:
Chapter |!18: |!Depressants |!Dermatologic |!Disorders |!Chapter
|!Chapter |!19: |!Antiseizure |!Drugs |!46: |!Pituitary, |!Thyroid, |!Parathyroid,
Chapter |!20: |!Drugs |!for |!Parkinsonism |!and |!and |!Adrenal |!Disorders |!Chapter |!47:
|!Alzheimer's |!Disease |!Antidiabetics
Chapter |!21: |!Drugs |!for |!Neuromuscular Chapter |!48: |!Urinary |!Disorders
|!Disorders |!and |!Muscle |!Spasms |!Chapter |!49: |!Pregnancy |!and |!Preterm
|!Chapter |!22: |!Antipsychotics |!and |!Labor
|!Anxiolytics Chapter |!50: |!Labor, |!Delivery, |!and
Chapter |!23: |!Antidepressants |!and |!Mood |!Postpartum
|!Stabilizers Chapter |!51: |!Neonatal |!and |!Newborn
Chapter |!24: |!Antiinflammatories |!Chapter |!52: |!W omen's |!Reproductive
Chapter |!25: |!Analgesics |!Health
Chapter |!26: |!Antibacterials Chapter |!53: |!Men's |!Reproductive |!Health
Chapter |!27: |!Antituberculars, |!Antifungals, |!Chapter |!54: |!Sexually |!TrANSmitted
|!and |!Antivirals |!Infections
Chapter |!55: |!Adult |!and |!Pediatric
,Test |!Bank |!- |!Pharmacology: |!A |!Patient-Centered |!Nursing |!Process |!Approach |!(9th |!Edition)
PHARMACOLOGY |!9TH |!EDITION |!MCCUISTION |!TEST |!BANK
Emergency |!Drugs
, Test |!Bank |!- |!Pharmacology: |!A |!Patient-Centered |!Nursing |!Process |!Approach |!(9th |!Edition)
PHARMACOLOGY |!9TH |!EDITION |!MCCUISTION |!TEST |!BANK
Chapter 01: Drug Development and Ethical Considerations
|! |! |! |! |! |!
MULTIPLE |!CHOICE
1. The |!nurse |!is |!preparing |!to |!administer |!a |!schedule |!II |!injectable |!drug |!and |!is |!drawing |!up |!half
|!of |!the |!contents |!of |!a |!Single-use |!vial. |!Which |!nursing |!action |!is |!correct?
a. Ask |!another |!nurse |!to |!observe |!and |!cosign |!wasting |!the |!remaining |!drug |!from |!the |!vial.
b. Keep |!the |!remaining |!amount |!in |!the |!patient’s |!drawer |!to |!give |!at |!the |!next |!dose.
c. Record |!the |!amount |!unused |!in |!the |!patient’s |!medication |!record.
d. Dispose |!of |!the |!vial |!with |!the |!remaining |!drug |!into |!a |!locked |!collection
|!box. |!ANS: |!A
Schedule |!II |!drugs |!are |!controlled |!substances, |!and |!all |!must |!be |!accounted |!for. |!When |!wasting |!a
|!portion |!of |!a |!drug, |!another |!nurse |!should |!observe |!and |!cosign |!that |!a |!drug |!was |!wasted.
DIF: |!COGNITIVE |!LEVEL: |!Applying |!(Application)
|!TOP: |!NURSING |!PROCESS: |!Nursing |!Intervention
MSC: |!NCLEX: |!Physiological |!Integrity: |!Pharmacological |!and |!Parenteral |!Therapies
2. A |!patient |!is |!prescribed |!a |!medication |!and |!asks |!the |!nurse |!if |!the |!drug |!is |!available |!in |!a
|!generic |!form. |!The |!nurse |!understands |!that |!a |!generic |!medication |!will |!have |!a |!name |!that
a. is |!a |!registered |!trademark.
b. is |!always |!capitalized.
c. describes |!the |!drugs |!chemical |!structure.
d. is |!non-proprietary.
|!ANS: |!D
The |!generic |!name |!is |!the |!official, |!non-proprietary |!name |!for |!a |!drug. |!The |!brand |!name |!is |!the
|!trademark |!name |!and |!is |!always |!capitalized. |!The |!chemical |!name |!describes |!the |!chemical
|!structure |!of |!the |!drug.
DIF: |!COGNITIVE |!LEVEL: |!Understanding |!(Comprehension)
|!TOP: |!NURSING |!PROCESS: |!N/A
MSC: |!NCLEX: |!Physiological |!Integrity: |!Pharmacological |!and |!Parenteral |!Therapies
3. A |!patient |!receives |!a |!prescription |!on |!which |!the |!provider |!has |!noted |!that |!a |!generic
|!medication |!may |!be |!given.The |!patient |!asks |!the |!nurse |!what |!this |!meANS. |!What |!will |!the |!nurse
|!tell |!the |!patient |!about |!generic |!drugs?
a. They |!contain |!the |!same |!inert |!ingredients |!as |!brand-name |!drugs.
b. They |!have |!chemical |!structures |!that |!are |!identical |!to |!proprietary |!drugs.
c. They |!tend |!to |!be |!less |!expensive |!than |!brand-name |!drugs.
d. They |!undergo |!extensive |!testing |!before |!they |!are
|!marketed. |!ANS: |!C
Generic |!drugs |!are |!approved |!by |!the |!FDA |!if |!they |!are |!proved |!to |!be |!bioequivalent |!to |!the |!brand-
|!name |!drug. |!They |!tend |!to |!be |!less |!expensive |!because |!manufacturers |!of |!these |!drugs |!do |!not
|!have |!to |!do |!the |!extensive |!testing |!required |!of |!brand-name |!drugs |!before |!marketing. |!They |!are
|!not |!identical |!to |!brand-name |!drugs |!and |!often |!have |!different |!inert |!ingredients.
DIF: |!COGNITIVE |!LEVEL: |!Applying |!(Application)
TOP: |!NURSING |!PROCESS: |!Nursing |!Intervention: |!Patient |!Teaching
|!MSC: |!NCLEX: |!Management |!of |!Client |!Care
4. The |!nurse |!reviews |!information |!about |!a |!drug |!and |!notes |!the |!initials |!USP |!after |!the |!drugs
|!official |!name. |!The |!nurse |!understands |!that |!this |!designation |!indicates |!the |!drug
a. is |!a |!controlled |!substance.
PHARMACOLOGY |!9TH |!EDITION |!MCCUISTION |!TEST |!BANK
This |!is |!a |!set |!of |!questions |!to |!ANSwer |!the |!questions |!of |!the |!textbook |!"Pharmacology: |!A |!Patient-
Centered |!Nursing |!Process |!Approach |!9th |!Edition" |!it |!helps |!you |!to |!better |!understand |!the |!book
|!correctly.
Get |!the |!right |!dosage |!of |!pharmacology |!content |!to |!succeed |!on |!the |!NCLEX |!and |!as |!a |!professional
|!nurse |!with |!"Pharmacology: |!A |!Patient-Centered |!Nursing |!Process |!Approach, |!9th |!Edition". |!Using |!a
|!streamlined |!prototype |!approach |!and |!an |!emphasis |!on |!nursing |!care, |!this |!text |!makes |!it |!easy |!for
|!today’s |!nursing |!students |!to |!better |!understand |!the |!complicated |!subject |!of |!pharmacology. |!The
|!book’s |!detailed |!chapter |!on |!dosage |!calculation, |!the |!nursing |!process |!framework |!for |!drug |!therapy,
|!strong |!QSEN |!focus, |!and |!summaries |!of |!prototype |!drugs |!help |!deliver |!the |!perfect.
,Test |!Bank |!- |!Pharmacology: |!A |!Patient-Centered |!Nursing |!Process |!Approach |!(9th |!Edition)
PHARMACOLOGY |!9TH |!EDITION |!MCCUISTION |!TEST |!BANK
Table of Contents
|! |!
Table |!of |!Contents Chapter |!28: |!Peptides, |!Antimalarial, |!and
Chapter |!01: |!Drug |!Development |!and Anthelmintic
|!Ethical |!Considerations Chapter |!29: |!HIV- |!and |!AIDS-Related
Chapter |!02: |!Pharmacokinetics, |!Drugs
|!Pharmacodynamics, |!and Chapter |!30: |!TrANSplant
|!Pharmacogenetics |!Drugs |!Chapter |!31: |!Vaccines
Chapter |!03: |!Cultural |!Considerations |!Chapter |!32: |!Anticancer |!Drugs
|!Chapter |!04: |!Complementary |!and Chapter |!33: |!Targeted |!Therapies |!to |!Treat
|!Alternative |!Therapies |!Cancer
Chapter |!05: |!Pediatric |!Considerations Chapter |!34: |!Biologic |!Response
|!Chapter |!06: |!Geriatric |!Modifiers
|!Considerations |!Chapter |!07: |!Drugs |!in Chapter |!35: |!Upper |!Respiratory
|!Substance |!Use |!Disorder |!Disorders
Chapter |!08: |!The |!Nursing |!Process |!and Chapter |!36: |!Lower |!Respiratory
|!Patient-Centered |!Care |!Disorders
Chapter |!09: |!Safety |!and |!Quality Chapter |!37: |!Cardiac |!Glycosides,
|!Chapter |!10: |!Drug |!Administration |!Antianginals, |!and |!Antidysrhythmics
|!Chapter |!11: |!Drug |!Calculations |!Chapter |!38: |!Diuretics
|!Chapter |!12: |!Fluid |!Volume |!and Chapter |!39: |!Antihypertensive
|!Electrolytes Chapter |!40: |!Anticoagulants,
Chapter |!13: |!Vitamin |!and |!Mineral |!Antiplatelets, |!and |!Thrombolytics
|!Replacement |!Chapter |!41: |!Antihyperlipidemics |!and
Chapter |!14: |!Nutritional |!Support |!Peripheral |!Vasodilators
|!Chapter |!15: |!Adrenergic |!Agonists |!and Chapter |!42: |!Gastrointestinal |!Tract
|!Antagonists |!Disorders
Chapter |!16: |!Cholinergic |!Agonists |!and Chapter |!43: |!Antiulcer |!Drugs
|!Antagonists |!Chapter |!44: |!Eye |!and |!Ear
Chapter |!17: |!Stimulants |!Disorders |!Chapter |!45:
Chapter |!18: |!Depressants |!Dermatologic |!Disorders |!Chapter
|!Chapter |!19: |!Antiseizure |!Drugs |!46: |!Pituitary, |!Thyroid, |!Parathyroid,
Chapter |!20: |!Drugs |!for |!Parkinsonism |!and |!and |!Adrenal |!Disorders |!Chapter |!47:
|!Alzheimer's |!Disease |!Antidiabetics
Chapter |!21: |!Drugs |!for |!Neuromuscular Chapter |!48: |!Urinary |!Disorders
|!Disorders |!and |!Muscle |!Spasms |!Chapter |!49: |!Pregnancy |!and |!Preterm
|!Chapter |!22: |!Antipsychotics |!and |!Labor
|!Anxiolytics Chapter |!50: |!Labor, |!Delivery, |!and
Chapter |!23: |!Antidepressants |!and |!Mood |!Postpartum
|!Stabilizers Chapter |!51: |!Neonatal |!and |!Newborn
Chapter |!24: |!Antiinflammatories |!Chapter |!52: |!W omen's |!Reproductive
Chapter |!25: |!Analgesics |!Health
Chapter |!26: |!Antibacterials Chapter |!53: |!Men's |!Reproductive |!Health
Chapter |!27: |!Antituberculars, |!Antifungals, |!Chapter |!54: |!Sexually |!TrANSmitted
|!and |!Antivirals |!Infections
Chapter |!55: |!Adult |!and |!Pediatric
,Test |!Bank |!- |!Pharmacology: |!A |!Patient-Centered |!Nursing |!Process |!Approach |!(9th |!Edition)
PHARMACOLOGY |!9TH |!EDITION |!MCCUISTION |!TEST |!BANK
Emergency |!Drugs
, Test |!Bank |!- |!Pharmacology: |!A |!Patient-Centered |!Nursing |!Process |!Approach |!(9th |!Edition)
PHARMACOLOGY |!9TH |!EDITION |!MCCUISTION |!TEST |!BANK
Chapter 01: Drug Development and Ethical Considerations
|! |! |! |! |! |!
MULTIPLE |!CHOICE
1. The |!nurse |!is |!preparing |!to |!administer |!a |!schedule |!II |!injectable |!drug |!and |!is |!drawing |!up |!half
|!of |!the |!contents |!of |!a |!Single-use |!vial. |!Which |!nursing |!action |!is |!correct?
a. Ask |!another |!nurse |!to |!observe |!and |!cosign |!wasting |!the |!remaining |!drug |!from |!the |!vial.
b. Keep |!the |!remaining |!amount |!in |!the |!patient’s |!drawer |!to |!give |!at |!the |!next |!dose.
c. Record |!the |!amount |!unused |!in |!the |!patient’s |!medication |!record.
d. Dispose |!of |!the |!vial |!with |!the |!remaining |!drug |!into |!a |!locked |!collection
|!box. |!ANS: |!A
Schedule |!II |!drugs |!are |!controlled |!substances, |!and |!all |!must |!be |!accounted |!for. |!When |!wasting |!a
|!portion |!of |!a |!drug, |!another |!nurse |!should |!observe |!and |!cosign |!that |!a |!drug |!was |!wasted.
DIF: |!COGNITIVE |!LEVEL: |!Applying |!(Application)
|!TOP: |!NURSING |!PROCESS: |!Nursing |!Intervention
MSC: |!NCLEX: |!Physiological |!Integrity: |!Pharmacological |!and |!Parenteral |!Therapies
2. A |!patient |!is |!prescribed |!a |!medication |!and |!asks |!the |!nurse |!if |!the |!drug |!is |!available |!in |!a
|!generic |!form. |!The |!nurse |!understands |!that |!a |!generic |!medication |!will |!have |!a |!name |!that
a. is |!a |!registered |!trademark.
b. is |!always |!capitalized.
c. describes |!the |!drugs |!chemical |!structure.
d. is |!non-proprietary.
|!ANS: |!D
The |!generic |!name |!is |!the |!official, |!non-proprietary |!name |!for |!a |!drug. |!The |!brand |!name |!is |!the
|!trademark |!name |!and |!is |!always |!capitalized. |!The |!chemical |!name |!describes |!the |!chemical
|!structure |!of |!the |!drug.
DIF: |!COGNITIVE |!LEVEL: |!Understanding |!(Comprehension)
|!TOP: |!NURSING |!PROCESS: |!N/A
MSC: |!NCLEX: |!Physiological |!Integrity: |!Pharmacological |!and |!Parenteral |!Therapies
3. A |!patient |!receives |!a |!prescription |!on |!which |!the |!provider |!has |!noted |!that |!a |!generic
|!medication |!may |!be |!given.The |!patient |!asks |!the |!nurse |!what |!this |!meANS. |!What |!will |!the |!nurse
|!tell |!the |!patient |!about |!generic |!drugs?
a. They |!contain |!the |!same |!inert |!ingredients |!as |!brand-name |!drugs.
b. They |!have |!chemical |!structures |!that |!are |!identical |!to |!proprietary |!drugs.
c. They |!tend |!to |!be |!less |!expensive |!than |!brand-name |!drugs.
d. They |!undergo |!extensive |!testing |!before |!they |!are
|!marketed. |!ANS: |!C
Generic |!drugs |!are |!approved |!by |!the |!FDA |!if |!they |!are |!proved |!to |!be |!bioequivalent |!to |!the |!brand-
|!name |!drug. |!They |!tend |!to |!be |!less |!expensive |!because |!manufacturers |!of |!these |!drugs |!do |!not
|!have |!to |!do |!the |!extensive |!testing |!required |!of |!brand-name |!drugs |!before |!marketing. |!They |!are
|!not |!identical |!to |!brand-name |!drugs |!and |!often |!have |!different |!inert |!ingredients.
DIF: |!COGNITIVE |!LEVEL: |!Applying |!(Application)
TOP: |!NURSING |!PROCESS: |!Nursing |!Intervention: |!Patient |!Teaching
|!MSC: |!NCLEX: |!Management |!of |!Client |!Care
4. The |!nurse |!reviews |!information |!about |!a |!drug |!and |!notes |!the |!initials |!USP |!after |!the |!drugs
|!official |!name. |!The |!nurse |!understands |!that |!this |!designation |!indicates |!the |!drug
a. is |!a |!controlled |!substance.
